Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
about
Engineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment.Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapySignificance and applications of nanoparticles in siRNA delivery for cancer therapy.Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapiesThe suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNAToward personalized cancer nanomedicine - past, present, and future.Assessment of the evolution of cancer treatment therapiesLipid-based systemic delivery of siRNA.Lipidic systems for in vivo siRNA delivery.Oligonucleotide delivery in cancer therapy.Strategies for tumor-directed delivery of siRNA.Research progress on siRNA delivery with nonviral carriers.Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors.Therapeutic siRNA: principles, challenges, and strategies.Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.siRNA therapeutics in the treatment of diseases.Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.Multifunctional nanoparticles for targeting cancer and inflammatory diseases.Delivery of RNAi therapeutics: work in progress.Nanomedicine: de novo design of nanodrugs.Liposomal siRNA nanocarriers for cancer therapy.Delivering the promise of small ncRNA therapeutics.Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.In vivo comparison of local versus systemic delivery of immunostimulating siRNA in HPV-driven tumours.Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis.Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells.PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.Chitosan nanoparticle carrying small interfering RNA to platelet-derived growth factor B mRNA inhibits proliferation of smooth muscle cells in rabbit injured arteries.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
P2860
Q28073956-BFA616AD-CF07-4949-B3FE-2779BDC0954DQ31043482-9CA97FB1-81DA-4AB2-8C7C-7601AE830ABAQ33549485-FBDF21C4-D650-4039-89FF-E101D741FA47Q33859472-9AA17229-14C1-4DA2-B985-9517956FD9B9Q34297263-BE653BE9-B518-4420-BE85-65C5018CDAE4Q34797004-0BC7EB17-CDBA-4025-8C1D-24E32D5E9BFBQ35764362-3EB721FA-BF34-4A1E-9D12-1CE6A594D4F0Q36472802-22A07D03-25A3-490A-B1CD-ADD56B437E7EQ37137408-BC66C73C-EDCB-470E-A344-8748D8A6E4DDQ37425606-E1D39710-1DB9-4152-85D0-2EAA6627391AQ37598096-DEF36CBC-11A8-43DF-B4DC-111F8D2A2B65Q37803214-A14FB6B1-2E25-4CD0-8CCA-BAEB6F0FB950Q37840092-7EBDABCA-111B-4CD1-9013-C890F0379F68Q37896464-A32A39A4-A77B-4C64-BAC8-56585DAE70B6Q38015528-BD08ABCF-7ADD-42A6-9935-691CE82E5B64Q38021996-5B24091F-2268-4627-9FF4-8E6DBFA0F15FQ38032893-8C40CB15-288D-433D-8162-D60B3A96E51BQ38074462-43E7D296-3769-4EC2-96EA-1795DB6AC8ADQ38090525-56EDA593-B2CE-4E95-822E-7BB0D478905EQ38136253-920CA194-82E2-461A-B979-501FAAEA325EQ38160246-71B071C0-3776-4E62-9E72-8D004FFA09AFQ38168683-611B9D88-C6BE-4568-8D80-5C759E985C35Q38175250-105532E1-B102-4EB6-8B95-3D3EF264AF3BQ38226666-AB086412-97DD-4301-8202-502E8DA80BD8Q38504825-F7152DD0-BDC9-47AA-BE93-92310CEFE482Q39064359-79896D76-EA86-4821-BFD4-9A3EC96140B1Q39668289-79B613A3-295E-4DC3-99F2-1D768898D25FQ39689841-7B42E6A7-6423-4494-B11D-F5CC9446C139Q41114317-044DF1B9-1D68-4873-B300-4B7CE93E0565Q45982870-23354ECD-04D8-4275-9C73-3222ED8D2ED9Q47152520-F2965F93-1F29-4FCF-A7DD-D9F47C332A62Q49593660-E1993D6B-9AB8-453C-B993-D800F9FCA9D0Q51022530-D7AE1CFA-B454-4B41-ADF4-4AFA5B21C56F
P2860
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Folate-linked lipid-based nano ...... livery in KB tumor xenografts.
@en
Folate-linked lipid-based nano ...... livery in KB tumor xenografts.
@nl
type
label
Folate-linked lipid-based nano ...... livery in KB tumor xenografts.
@en
Folate-linked lipid-based nano ...... livery in KB tumor xenografts.
@nl
prefLabel
Folate-linked lipid-based nano ...... livery in KB tumor xenografts.
@en
Folate-linked lipid-based nano ...... livery in KB tumor xenografts.
@nl
P2093
P1476
Folate-linked lipid-based nano ...... elivery in KB tumor xenografts
@en
P2093
Kimiko Koga
Motoki Hakoshima
Takashi Yoshizawa
Yoshie Maitani
P304
P356
10.1016/J.EJPB.2008.06.026
P407
P577
2008-07-04T00:00:00Z